UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4274-4282

2020

Volltextzugriff (PDF)

Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5305-5313

2005

Volltextzugriff (PDF)

Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy

Breast (Edinburgh), 2015-10, Vol.24 (5), p.630-636

2015

Volltextzugriff (PDF)

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2502-2512

2005

Volltextzugriff (PDF)

Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2198-2206

2010

Volltextzugriff (PDF)

Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial

Journal of the American College of Surgeons, 2009-05, Vol.208 (5), p.906-914

2009

Volltextzugriff (PDF)

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

Molecular cancer research, 2011-08, Vol.9 (8), p.997-1007

2011

Volltextzugriff (PDF)

Vaccine-Induced Memory CD8 + T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Clinical cancer research, 2019-05, Vol.25 (9), p.2725-2736

2019

Volltextzugriff (PDF)

Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions

Breast cancer research and treatment, 2022-11, Vol.196 (1), p.215-220

2022

Volltextzugriff (PDF)

Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer

Breast cancer research and treatment, 2015-07, Vol.152 (2), p.347-356

2015

Volltextzugriff (PDF)

Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy

Supportive care in cancer, 2014-10, Vol.22 (10), p.2851-2859

2014

Volltextzugriff (PDF)

A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer

Clinical breast cancer, 2018-08, Vol.18 (4), p.289-297

2018

Volltextzugriff (PDF)

Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care

Breast cancer research and treatment, 2009-12, Vol.118 (3), p.635-643, Article 635

2009

Volltextzugriff (PDF)

Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables

Journal of biophotonics, 2020-10, Vol.13 (10), p.e201960235-n/a

2020

Volltextzugriff (PDF)

Retinoic Acid Receptor-β2 Promoter Methylation in Random Periareolar Fine Needle Aspiration

Cancer epidemiology, biomarkers & prevention, 2005-04, Vol.14 (4), p.790-798

2005

Volltextzugriff (PDF)

Hypermethylation of the Breast Cancer–Associated Gene 1 Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer Risk

Cancer epidemiology, biomarkers & prevention, 2007-01, Vol.16 (1), p.50-56

2007

Volltextzugriff (PDF)

Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer

Journal of geriatric oncology, 2019-03, Vol.10 (2), p.317-321

2019

Volltextzugriff (PDF)

Detecting geriatric needs in older patients with breast cancer through use of a brief geriatric screening tool

Journal of geriatric oncology, 2019-11, Vol.10 (6), p.968-972

2019

Volltextzugriff (PDF)

Benefit or bias? The role of surgery to remove the primary tumor in patients with metastatic breast cancer

Annals of surgery, 2008-05, Vol.247 (5), p.739-740

2008

Volltextzugriff (PDF)

Optimizing the quality of breast cancer biomarker use at Duke Cancer Institute

Journal of the National Comprehensive Cancer Network, 2014-02, Vol.12 Suppl 1, p.S21

2014

Volltextzugriff (PDF)

Symptom Communication in Breast Cancer: Relationships of Holding Back and Self-Efficacy for Communication to Symptoms and Adjustment

Journal of psychosocial oncology, 2013-11, Vol.31 (6), p.698-711

2013

Volltextzugriff (PDF)

Abstract P4-02-05: Predictors of long-term durable response in de novo HER2 positive metastatic breast cancer and the real world treatment experience at two institutions

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-02-05

2023

Volltextzugriff (PDF)

Abstract P3-06-09: Incidence of ROS1 genomic alterations in breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-06-09

2020

Volltextzugriff (PDF)

Abstract SS1-11: Comprehensive analysis of health services, sociodemographic, clinical, and genomic factors driving locally advanced breast cancer mortality via a first-in-kind linkage of SEER-Medicare data with physical tumor samples

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.SS1-11-SS1-11

2021

Volltextzugriff (PDF)

Is advanced imaging in early-stage breast cancer ever warranted? Exploring benchmarks for an ASCO Choosing Wisely quality measure

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6503-6503

2014

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas

Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome

Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

Vaccine-Induced Memory CD8 + T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions

Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer

Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy

A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer

Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care

Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables

Retinoic Acid Receptor-β2 Promoter Methylation in Random Periareolar Fine Needle Aspiration

Hypermethylation of the Breast Cancer–Associated Gene 1 Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer Risk

Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer

Detecting geriatric needs in older patients with breast cancer through use of a brief geriatric screening tool

Benefit or bias? The role of surgery to remove the primary tumor in patients with metastatic breast cancer

Optimizing the quality of breast cancer biomarker use at Duke Cancer Institute

Symptom Communication in Breast Cancer: Relationships of Holding Back and Self-Efficacy for Communication to Symptoms and Adjustment

Abstract P4-02-05: Predictors of long-term durable response in de novo HER2 positive metastatic breast cancer and the real world treatment experience at two institutions

Abstract P3-06-09: Incidence of ROS1 genomic alterations in breast cancer

Abstract SS1-11: Comprehensive analysis of health services, sociodemographic, clinical, and genomic factors driving locally advanced breast cancer mortality via a first-in-kind linkage of SEER-Medicare data with physical tumor samples

Is advanced imaging in early-stage breast cancer ever warranted? Exploring benchmarks for an ASCO Choosing Wisely quality measure

Suchergebnisse filtern